{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T04:11:09Z","timestamp":1790655069088,"version":"4.1.0"},"reference-count":68,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,4,21]],"date-time":"2020-04-21T00:00:00Z","timestamp":1587427200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010751","name":"Fondo Nacional de Desarrollo Cient\u00edfico, Tecnol\u00f3gico y de Innovaci\u00f3n Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["1160695"],"award-info":[{"award-number":["1160695"]}],"id":[{"id":"10.13039\/501100010751","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007397","name":"Instituto Millenium","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007397","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009068","name":"Consejo Nacional de Innovaci\u00f3n, Ciencia y Tecnolog\u00eda","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009068","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2020.00223","type":"journal-article","created":{"date-parts":[[2020,4,21]],"date-time":"2020-04-21T00:26:36Z","timestamp":1587428796000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":20,"title":["Eplerenone Implantation Improved Adipose Dysfunction Averting RAAS Activation and Cell Division"],"prefix":"10.3389","volume":"11","author":[{"given":"Andrea","family":"Vecchiola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Crist\u00f3bal A.","family":"Fuentes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isidora","family":"Solar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos F.","family":"Lagos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Cecilia","family":"Opazo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Mu\u00f1oz-Durango","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia A.","family":"Riedel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gareth I.","family":"Owen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis M.","family":"Kalergis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos E.","family":"Fardella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,4,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.1253\/circj.CJ-14-0850","article-title":"Global trend in overweight and obesity and its association with cardiovascular disease incidence","volume":"78","author":"Yatsuya","year":"2014","journal-title":"Circ J"},{"key":"B2","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1056\/NEJMoa1614362","article-title":"Health effects of overweight and obesity in 195 countries over 25 years","volume":"377","author":"GBD","year":"2017","journal-title":"N Engl J Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s11906-016-0626-9","article-title":"Aldosterone production and signaling dysregulation in obesity","volume":"18","author":"Vecchiola","year":"2016","journal-title":"Curr Hyper Rep"},{"key":"B4","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s11154-014-9301-0","article-title":"Adipocyte dysfunction, inflammation and metabolic syndrome","volume":"15","author":"Kl\u00f6ting","year":"2014","journal-title":"Rev Endocr Metab Dis"},{"key":"B5","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1146\/annurev-immunol-031210-101322","article-title":"Inflammatory mechanisms in obesity","volume":"29","author":"Gregor","year":"2011","journal-title":"Ann Rev Immunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1161\/CIRCULATIONAHA.107.748640","article-title":"Mineralocorticoid receptor blockade reverses obesity-related changes in expression of adiponectin, peroxisome proliferator-activated receptor-\u03b3, and proinflammatory adipokines","volume":"117","author":"Guo","year":"2008","journal-title":"Circulation."},{"key":"B7","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1093\/cvr\/cvp191","article-title":"Blockade of mineralocorticoid receptor reverses adipocyte dysfunction and insulin resistance in obese mice","volume":"84","author":"Hirata","year":"2009","journal-title":"Cardiovasc Res"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1096\/fj.06-7970com","article-title":"Pivotal role of the mineralocorticoid receptor in corticosteroid-induced adipogenesis","volume":"21","author":"Caprio","year":"2007","journal-title":"FASEB J"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1002\/cphy.c160037","article-title":"Impact of adrenal steroids on regulation of adipose tissue","volume":"7","author":"Infante","year":"2017","journal-title":"Compr Physiol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.steroids.2014.05.001","article-title":"Mineralocorticoid receptor in adipocytes and macrophages: a promising target to fight metabolic syndrome","volume":"91","author":"Marzolla","year":"2014","journal-title":"Steroids"},{"key":"B11","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1161\/HYPERTENSIONAHA.114.04981","article-title":"Adipocyte mineralocorticoid receptor activation leads to metabolic syndrome and induction of prostaglandin D2 synthase","volume":"66","author":"Urbanet","year":"2015","journal-title":"Hypertension"},{"key":"B12","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1210\/en.2009-0869","article-title":"Spironolactone improves glucose and lipid metabolism by ameliorating hepatic steatosis and inflammation and suppressing enhanced gluconeogenesis induced by high-fat and high-fructose diet","volume":"151","author":"Wada","year":"2010","journal-title":"Endocrinology"},{"key":"B13","doi-asserted-by":"publisher","first-page":"3745","DOI":"10.1096\/fj.13-245415","article-title":"Mineralocorticoid receptor antagonism induces browning of white adipose tissue through impairment of autophagy and prevents adipocyte dysfunction in high-fat-diet-fed mice","volume":"28","author":"Armani","year":"2014","journal-title":"FASEB J"},{"key":"B14","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1210\/en.2010-0674","article-title":"Antiadipogenic effects of the mineralocorticoid receptor antagonist drospirenone: potential implications for the treatment of metabolic syndrome","volume":"152","author":"Caprio","year":"2011","journal-title":"Endocrinology"},{"key":"B15","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1089\/met.2015.0044","article-title":"Effect of selective mineralocorticoid receptor blockade on flow-mediated dilation and insulin resistance in older adults with metabolic syndrome","volume":"13","author":"Hwang","year":"2015","journal-title":"Metab Syndr Relat Dis"},{"key":"B16","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1042\/CS20140758","article-title":"Mineralocorticoid receptor blockade prevents vascular remodelling in a rodent model of type 2 diabetes mellitus","volume":"129","author":"Silva","year":"2015","journal-title":"Clin Sci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1530\/JOE-17-0351","article-title":"Eplerenone prevented obesity-induced inflammasome activation and glucose intolerance","volume":"235","author":"Wada","year":"2017","journal-title":"J Endocrinol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1080\/08998280.2004.11927973","article-title":"Eplerenone (Inspra), a new aldosterone antagonist for the treatment of systemic hypertension and heart failure","volume":"17","author":"Craft","year":"2004","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1172\/JCI57132","article-title":"Inflammatory links between obesity and metabolic disease","volume":"121","author":"Lumeng","year":"2011","journal-title":"J Clin Investig"},{"key":"B20","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/j.1467-789X.2011.00942.x","article-title":"The renin-angiotensin system: a link between obesity, inflammation and insulin resistance","volume":"13","author":"Kalupahana","year":"2012","journal-title":"Obes Rev"},{"key":"B21","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.mce.2011.09.011","article-title":"The role of the mineralocorticoid receptor in adipocyte biology and fat metabolism","volume":"350","author":"Marzolla","year":"2012","journal-title":"Mol Cell Endocrinol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/S0140-6736(07)60242-6","article-title":"Renin-angiotensin system and cardiovascular risk","volume":"369","author":"Schmieder","year":"2007","journal-title":"Lancet"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1210\/endo-121-5-1616","article-title":"Cellular localization of angiotensinogen gene expression in brown adipose tissue and mesentery: quantification of messenger ribonucleic acid abundance using hybridization in situ","volume":"121","author":"Campbell","year":"1987","journal-title":"Endocrinology"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1161\/01.RES.62.6.1259","article-title":"Localization of angiotensinogen messenger RNA in rat aorta","volume":"62","author":"Cassis","year":"1988","journal-title":"Circ Res"},{"key":"B25","doi-asserted-by":"publisher","first-page":"E260","DOI":"10.1152\/ajpendo.1994.267.2.E260","article-title":"Differential expression of angiotensin receptor 1A and 1B in mouse","volume":"267","author":"Burson","year":"1994","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B26","doi-asserted-by":"publisher","first-page":"R236","DOI":"10.1152\/ajpregu.1997.273.1.R236","article-title":"Angiotensinogen gene expression in adipose tissue: analysis of obese models and hormonal and nutritional control","volume":"273","author":"Jones","year":"1997","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"3925","DOI":"10.1210\/jcem.83.11.5276","article-title":"Human adipose tissue expresses angiotensinogen and enzymes required for its conversion to angiotensin II1","volume":"83","author":"Karlsson","year":"","journal-title":"J Clin Endocrinol Metab."},{"key":"B28","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1097\/00004872-199917040-00014","article-title":"Co-expression of renin-angiotensin system genes in human adipose tissue","volume":"17","author":"Engeli","year":"1999","journal-title":"J Hyper"},{"key":"B29","doi-asserted-by":"publisher","first-page":"R274","DOI":"10.1152\/ajpregu.00439.2005","article-title":"Renin receptor expression in human adipose tissue","volume":"292","author":"Achard","year":"2007","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1677\/JOE-07-0284","article-title":"Comparative expression analysis of the renin\u2013angiotensin system components between white and brown perivascular adipose tissue","volume":"197","author":"G\u00e1lvez-Prieto","year":"2008","journal-title":"J Endocrinol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1161\/HYPERTENSIONAHA.111.190223","article-title":"Adipocytes produce aldosterone through calcineurin-dependent signaling pathways","volume":"59","author":"Briones Ana","year":"2012","journal-title":"Hypertension"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mce.2012.06.021","article-title":"Adipose tissue renin\u2013angiotensin\u2013aldosterone system (RAAS) and progression of insulin resistance","volume":"378","author":"Marcus","year":"2013","journal-title":"Mol Cell Endocrinol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1111\/j.1476-5381.2010.00872.x","article-title":"Animal research: Reporting in vivo experiments: the ARRIVE guidelines","volume":"160","author":"Kilkenny","year":"2010","journal-title":"Br J Pharmacol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"3189","DOI":"10.1111\/bph.12955","article-title":"Implementing guidelines on reporting research using animals (ARRIVE etc.): new requirements for publication in BJP","volume":"172","author":"Mcgrath","year":"2015","journal-title":"Br J Pharmacol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1093\/cvr\/cvx162","article-title":"Diverging effects of enalapril or eplerenone in primary prevention against doxorubicin-induced cardiotoxicity","volume":"114","author":"Hullin","year":"2017","journal-title":"Cardiovasc Res"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.3390\/ijms18061250","article-title":"Eplerenone-resistant salt-sensitive hypertension in Nedd4-2 C2 KO mice","volume":"18","author":"Kino","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B37","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3233\/JND-160173","article-title":"Similar efficacy from specific and non-specific mineralocorticoid receptor antagonist treatment of muscular dystrophy mice","volume":"3","author":"Lowea","year":"2016","journal-title":"Neuromuscul Dis"},{"key":"B38","doi-asserted-by":"publisher","first-page":"E445","DOI":"10.1152\/ajpendo.00638.2011","article-title":"Central versus peripheral impact of estradiol on the impaired glucose metabolism in ovariectomized mice on a high-fat diet","volume":"303","author":"Yonezawa","year":"2012","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B39","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2013\u0394\u0394CT method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"B40","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","article-title":"A new mathematical model for relative quantification in real-time RT\u2013PCR","volume":"29","author":"Pfaffl","year":"2001","journal-title":"Nucleic Acids Res"},{"key":"B41","doi-asserted-by":"publisher","first-page":"F1670","DOI":"10.1152\/ajprenal.00391.2018","article-title":"Periarterial fat from two human vascular beds is not a source of aldosterone to promote vasoconstriction","volume":"315","author":"Assersen","year":"2018","journal-title":"Am J Physiol Renal Physiol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1111\/liv.13734","article-title":"Unanticipated increases in hepatic steatosis among human immunodeficiency virus patients receiving mineralocorticoid receptor antagonist eplerenone for non-alcoholic fatty liver disease","volume":"38","author":"Chaudhury","year":"2018","journal-title":"Liver Int"},{"key":"B43","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1161\/HYPERTENSIONAHA.116.07806","article-title":"Body mass index predicts 24-hour urinary aldosterone levels in patients with resistant Hypertension","volume":"68","author":"Dudenbostel","year":"2016","journal-title":"Hypertension"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1172\/JCI1915","article-title":"Hibernoma development in transgenic mice identifies brown adipose tissue as a novel target of aldosterone action","volume":"101","author":"Zennaro","year":"1998","journal-title":"J Clin Investig"},{"key":"B45","doi-asserted-by":"publisher","first-page":"E386","DOI":"10.1152\/ajpendo.2000.279.2.E386","article-title":"The mineralocorticoid receptor mediates aldosterone-induced differentiation of T37i cells into brown adipocytes","volume":"279","author":"Penfornis","year":"2000","journal-title":"Am J Physiol Endocrinol Metabol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/BF00456122","article-title":"Effect of adrenal steroids on insulin release from cultured rat islets of Langerhans","volume":"29","author":"Pierluissi","year":"1986","journal-title":"Diabetologia"},{"key":"B47","doi-asserted-by":"publisher","first-page":"eS61","DOI":"10.1097\/00005344-199406243-00011","article-title":"Insulin and the renin-angiotensin-aldosterone system: influence of ACE inhibition","volume":"24","author":"Ferrannini","year":"1994","journal-title":"J Cardiovasc Pharmacol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1097\/HJH.0b013e3282861fa4","article-title":"A possible association between primary aldosteronism and a lower \u03b2-cell function","volume":"25","author":"Mosso","year":"2007","journal-title":"J Hyper"},{"key":"B49","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s11906-015-0567-8","article-title":"Aldosterone and the mineralocorticoid receptor: risk factors for cardiometabolic disorders","volume":"17","author":"Garg","year":"2015","journal-title":"Curr Hyper Rep"},{"key":"B50","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/S0960-0760(03)00072-4","article-title":"Transcriptional inhibition of the human insulin receptor gene by aldosterone","volume":"84","author":"Calle","year":"2003","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1530\/JOE-14-0471","article-title":"Mineralocorticoid receptors in the heart: lessons from cell-selective transgenic animals","volume":"224","author":"Morag","year":"2015","journal-title":"J Endocrinol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/hr.2015.129","article-title":"Comparison of eplerenone and spironolactone for the treatment of primary aldosteronism","volume":"39","author":"Karashima","year":"2016","journal-title":"Hypertens Res"},{"key":"B53","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/S0895-7061(02)02257-4","article-title":"Overexpression of the renin-angiotensin system in human visceral adipose tissue in normal and overweight subjects","volume":"15","author":"Giacchetti","year":"2002","journal-title":"Am J Hyper"},{"key":"B54","doi-asserted-by":"publisher","first-page":"R943","DOI":"10.1152\/ajpregu.00265.2004","article-title":"Activation of the systemic and adipose renin-angiotensin system in rats with diet-induced obesity and hypertension","volume":"287","author":"Boustany","year":"2004","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1172\/JCI117803","article-title":"The serum angiotensinogen concentration and variants of the angiotensinogen gene in white and black children","volume":"95","author":"Bloem","year":"1995","journal-title":"J Clin Investig"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1161\/01.CIR.0000161954.17870.5D","article-title":"Insulin-mediated upregulation of the renin angiotensin system in human subcutaneous adipocytes is reduced by rosiglitazone","volume":"111","author":"Harte","year":"2005","journal-title":"Circulation"},{"key":"B57","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1161\/01.HYP.0000154361.47683.d3","article-title":"Weight loss and the renin-angiotensin-aldosterone system","volume":"45","author":"Engeli","year":"2005","journal-title":"Hypertension"},{"key":"B58","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.beem.2005.07.002","article-title":"Mineralocorticoid-stimulating activity of adipose tissue","volume":"19","author":"Lamounier-Zepter","year":"2005","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1161\/HYPERTENSIONAHA.107.109439","article-title":"Aldosterone and metabolic syndrome","volume":"51","author":"Krug Alexander","year":"2008","journal-title":"Hypertension"},{"key":"B60","doi-asserted-by":"publisher","first-page":"E1383","DOI":"10.1152\/ajpendo.00025.2009","article-title":"Regulated renin release from 3T3-L1 adipocytes","volume":"296","author":"Fowler","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B61","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1161\/CIRCULATIONAHA.115.018226","article-title":"Adipocyte-derived hormone leptin is a direct regulator of aldosterone secretion, which promotes endothelial dysfunction and cardiac fibrosis","volume":"132","author":"Huby","year":"2015","journal-title":"Circulation."},{"key":"B62","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.1210\/endo.132.6.8504747","article-title":"Aldosterone stimulated differentiation of mouse 3T3-L1 cells into adipocytes","volume":"132","author":"Rondinone","year":"1993","journal-title":"Endocrinology"},{"key":"B63","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1081\/ERC-200044122","article-title":"Fat cells may be the obesity\u2013hypertension link: human adipogenic factors stimulate aldosterone secretion from adrenocortical cells","volume":"30","author":"Ehrhart-Bornstein","year":"2004","journal-title":"Endocr Res"},{"key":"B64","first-page":"414","article-title":"Decreased insulin receptor number and affinity in subcutaneous adipose tissue in a patient with primary hyperaldosteronism","volume":"188","author":"Carranza","year":"1991","journal-title":"Rev Clin Esp."},{"key":"B65","doi-asserted-by":"publisher","first-page":"3650","DOI":"10.4049\/jimmunol.1600820","article-title":"Adipose tissue dendritic cells are independent contributors to obesity-induced inflammation and insulin resistance","volume":"197","author":"Cho","year":"2016","journal-title":"J Immunol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.2337\/db11-1274","article-title":"Identification of adipose tissue dendritic cells correlated with obesity-associated insulin-resistance and inducing Th17 responses in mice and patients","volume":"61","author":"Bertola","year":"2012","journal-title":"Diabetes"},{"key":"B67","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1111\/imm.12653","article-title":"Dendritic cells and adipose tissue","volume":"149","author":"Sundara Rajan","year":"2016","journal-title":"Immunology"},{"key":"B68","first-page":"349","article-title":"Atherosclerosis","volume-title":"Biochemistry and Pathology of Basement Membranes 2014; Role in Diabetes","author":"Adams","year":"1980"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2020.00223\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,21]],"date-time":"2020-04-21T00:26:40Z","timestamp":1587428800000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2020.00223\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,21]]},"references-count":68,"alternative-id":["10.3389\/fendo.2020.00223"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2020.00223","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,21]]},"article-number":"223"}}